» Articles » PMID: 9989990

Macrophage Microbicidal Mechanisms in Vivo: Reactive Nitrogen Versus Oxygen Intermediates in the Killing of Intracellular Visceral Leishmania Donovani

Overview
Journal J Exp Med
Date 1999 Feb 17
PMID 9989990
Citations 152
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the relative contributions of respiratory burst-derived reactive oxygen intermediates (ROI) versus reactive nitrogen intermediates (RNI) to macrophage-mediated intracellular host defense, mice genetically deficient in these mechanisms were challenged with Leishmania donovani, a protozoan that selectively parasitizes visceral tissue macrophages. During the early stage of liver infection at wk 2, both respiratory burst-deficient gp91(phox)-/- (X-linked chronic granulomatous disease [X-CGD]) mice and inducible nitric oxide synthase (iNOS) knockout (KO) mice displayed comparably increased susceptibility. Thereafter, infection was unrestrained in mice lacking iNOS but was fully controlled in X-CGD mice. Mononuclear cell influx into infected liver foci in X-CGD and iNOS KO mice was also overtly impaired at wk 2. However, granuloma assembly in parasitized tissue eventually developed in both hosts but with divergent effects: mature granulomas were functionally active (leishmanicidal) in X-CGD mice but inert in iNOS-deficient animals. These results suggest that (a) ROI and RNI probably act together in the early stage of intracellular infection to regulate both tissue recruitment of mononuclear inflammatory cells and the initial extent of microbial replication, (b) RNI alone are necessary and sufficient for eventual control of visceral infection, and (c) although mature granulomas have traditionally been associated with control of such infections, these structures fail to limit intracellular parasite replication in the absence of iNOS.

Citing Articles

reduces parasite load and modulates cytokines in BALB/c mice infected with (Leishmania) .

Brigido H, Varela E, Gomes A, Neves Cruz J, Correa-Barbosa J, Siqueira J Front Chem. 2024; 12:1492770.

PMID: 39552719 PMC: 11565433. DOI: 10.3389/fchem.2024.1492770.


Investigation of potential ascorbate peroxidase inhibitors for anti-leishmaniasis therapy.

Rabaan A, Alshahrani M, Othman B, Alfaresi M, Almutawif Y, Eid H Folia Microbiol (Praha). 2024; .

PMID: 39153157 DOI: 10.1007/s12223-024-01190-z.


Innate biosignature of treatment failure in human cutaneous leishmaniasis.

Gomez M, Belew A, Vargas D, Giraldo-Parra L, Rebellon-Sanchez D, Alexander T Res Sq. 2024; .

PMID: 38746226 PMC: 11092798. DOI: 10.21203/rs.3.rs-4271873/v1.


Access and utilization of host-derived iron by Leishmania parasites.

Goto Y, Ito T, Ghosh S, Mukherjee B J Biochem. 2023; 175(1):17-24.

PMID: 37830941 PMC: 10771036. DOI: 10.1093/jb/mvad082.


Therapeutic potential of rWnt5A in curbing infection.

Maity S, Sengupta S, Sen M Infect Immun. 2023; 91(10):e0026723.

PMID: 37725061 PMC: 10580910. DOI: 10.1128/iai.00267-23.


References
1.
Shiloh M, MacMicking J, Nicholson S, Brause J, Potter S, Marino M . Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity. 1999; 10(1):29-38. DOI: 10.1016/s1074-7613(00)80004-7. View

2.
Murray H, Teitelbaum R . L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J Infect Dis. 1992; 165(3):513-7. DOI: 10.1093/infdis/165.3.513. View

3.
Roach T, Kiderlen A, Blackwell J . Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains. Infect Immun. 1991; 59(11):3935-44. PMC: 258980. DOI: 10.1128/iai.59.11.3935-3944.1991. View

4.
Murray H . Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis. J Infect Dis. 1990; 161(5):992-4. DOI: 10.1093/infdis/161.5.992. View

5.
Murray H, Wellner D, Oca M, Granger A, Libby D, Rothermel C . Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages. Infect Immun. 1989; 57(3):845-9. PMC: 313187. DOI: 10.1128/iai.57.3.845-849.1989. View